Skip to main content

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

PPI Directory

PPI Themes
Research Field
Organisation Type
Development Stage
Audience
Country
Content Type
  • PPI Pools/Lists of Organisations
  • Knowledge Building
Showing 5 of 86 results.
Page 7 of 18
2020

Improving patient access to gene and cell therapies for rare diseases in Europe.

Report for the Rare Impact project - improving access to ATMPs by European Organisation for Rare Diseases (EURORDIS)

Research Field

  • ATMP/Gene Therapy Development

Organisation Type

  • Third Sector/Charity

Development Stage

  • Service Delivery

Audience

  • Researchers/Developers
  • Public/Patients
  • Charity Sector
  • Industry

Country

  • Europe

Content Type

  • Resource
2016

PREFER patient preferences project

PREFER project by European Patient Forum (EPF)

Research Field

  • General

Organisation Type

  • Third Sector/Charity

Development Stage

  • Identifying/Prioritising Patient Need
  • Research and Clinical Development
  • Regulatory Approval
  • Health Technology Assessment
  • Service Delivery

Audience

  • Researchers/Developers
  • Industry

Country

  • Europe

Content Type

  • Resource
2020

Health Outcomes Observatory (H2O) project

Project by European Patient Forum (EPF)

Research Field

  • General
  • Biomedical Lab
  • Pharmaceutical

Organisation Type

  • Third Sector/Charity

Development Stage

  • Identifying/Prioritising Patient Need
  • Research and Clinical Development

Audience

  • Researchers/Developers
  • Public/Patients
  • Charity Sector
  • Industry

Country

  • Europe

Content Type

  • Resource
2014

Revised framework for interaction between the European Medicines Agency and patients and consumers and their organisations

Generic PPI framework by the European Medicines Agency

Research Field

  • Other

Organisation Type

  • Regulatory Body

Development Stage

  • Regulatory Approval

Audience

  • Researchers/Developers
  • Public/Patients

Country

  • Europe

Content Type

  • Resource
2020

EMA Regulatory Science to 2025 - strategic reflection

Report reflecting on the EMA's regulatory framework by the European Medicines Agency

Research Field

  • Other

Organisation Type

  • Regulatory Body

Development Stage

  • Regulatory Approval

Audience

  • Researchers/Developers
  • Public/Patients

Country

  • Europe

Content Type

  • Resource